Neogenomics Stock Price on December 1, 2024
| NEO Stock | USD 17.73 0.01 0.06% |
Below is the normalized historical share price chart for NeoGenomics extending back to November 10, 1999. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NeoGenomics stands at 17.73, as last reported on the 2nd of December, with the highest price reaching 17.97 and the lowest price hitting 17.61 during the day.
If you're considering investing in NeoGenomics Stock, it is important to understand the factors that can impact its price. NeoGenomics appears to be not too volatile, given 3 months investment horizon. NeoGenomics has Sharpe Ratio of 0.0787, which conveys that the firm had a 0.0787% return per unit of risk over the last 3 months. We have found thirty technical indicators for NeoGenomics, which you can use to evaluate the volatility of the firm. Please exercise NeoGenomics' Mean Deviation of 2.0, risk adjusted performance of 0.0531, and Downside Deviation of 2.63 to check out if our risk estimates are consistent with your expectations.
At this time, NeoGenomics' Sale Purchase Of Stock is very stable compared to the past year. As of the 2nd of December 2024, Stock Based Compensation To Revenue is likely to grow to 0.04, while Common Stock Total Equity is likely to drop about 102.7 K. . As of the 2nd of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.61, while Price To Sales Ratio is likely to drop 3.26. NeoGenomics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of November 1999 | 200 Day MA 14.9425 | 50 Day MA 14.7146 | Beta 1.183 |
NeoGenomics |
Sharpe Ratio = 0.0787
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NEO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.64 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average NeoGenomics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeoGenomics by adding it to a well-diversified portfolio.
Price Book 2.5059 | Enterprise Value Ebitda (27.92) | Price Sales 3.5352 | Shares Float 126.6 M | Wall Street Target Price 20.9091 |
Related Headline
Natera Headline on 29th of November 2024
Natera, Inc. is Fred Alger Management LLCs 7th Largest Posit... by thelincolnianonline.com
Fred Alger Management LLC decreased its position in Natera, Inc. by 23.8 percent during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission . The fund owned 4,012,000 shares of the medical research companys stock after selling 1,250,664 shares during the quarter. Natera
NeoGenomics Valuation on December 1, 2024
It is possible to determine the worth of NeoGenomics on a given historical date. On December 1, 2024 NeoGenomics was worth 17.84 at the beginning of the trading date compared to the closed value of 17.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NeoGenomics stock. Still, in general, we apply an absolute valuation method to find NeoGenomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NeoGenomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NeoGenomics' related companies.
| Open | High | Low | Close | Volume | |
| 17.31 | 17.78 | 17.31 | 17.74 | 446,248 | |
11/29/2024 | 17.84 | 17.97 | 17.61 | 17.73 | 336,968 |
| 17.84 | 17.97 | 17.61 | 17.73 | 0.00 |
| Backtest NeoGenomics | | | NeoGenomics History | | | NeoGenomics Valuation | Previous | Next |
NeoGenomics Trading Date Momentum on December 1, 2024
| On December 02 2024 NeoGenomics was traded for 17.73 at the closing time. Highest NeoGenomics's price during the trading hours was 17.97 and the lowest price during the day was 17.61 . There was no trading activity during the period 0.0. Lack of trading volume on the 2nd of December did not cause price change. The trading delta at closing time to current price is 0.62% . |
NeoGenomics Fundamentals Correlations and Trends
By evaluating NeoGenomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NeoGenomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NeoGenomics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NeoGenomics Stock history
NeoGenomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeoGenomics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeoGenomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeoGenomics stock prices may prove useful in developing a viable investing in NeoGenomics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 125.5 M | 131.8 M | |
| Net Loss | -129.8 M | -123.3 M |
NeoGenomics Quarterly Net Working Capital |
|
NeoGenomics Stock Technical Analysis
NeoGenomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NeoGenomics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
NeoGenomics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NeoGenomics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how NeoGenomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeoGenomics shares will generate the highest return on investment. By undertsting and applying NeoGenomics stock market strength indicators, traders can identify NeoGenomics entry and exit signals to maximize returns
NeoGenomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeoGenomics' price direction in advance. Along with the technical and fundamental analysis of NeoGenomics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeoGenomics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0531 | |||
| Jensen Alpha | 0.0131 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.0083 | |||
| Treynor Ratio | 0.1398 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeoGenomics. If investors know NeoGenomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeoGenomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.306 | Earnings Share (0.61) | Revenue Per Share 5.098 | Quarterly Revenue Growth 0.104 | Return On Assets (0.03) |
The market value of NeoGenomics is measured differently than its book value, which is the value of NeoGenomics that is recorded on the company's balance sheet. Investors also form their own opinion of NeoGenomics' value that differs from its market value or its book value, called intrinsic value, which is NeoGenomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeoGenomics' market value can be influenced by many factors that don't directly affect NeoGenomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeoGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeoGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeoGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.